
Chloromethanesulfonyl chloride | CAS:3518-65-8
Chloromethanesulfonyl chloride
- Name:Chloromethanesulfonyl chloride
- CAS:3518-65-8
- Synonyms:Chloromesyl chloride
- Molecular Formula:CH2Cl2O2S
- Molecular Weight:149.00
- EINESC:222-526-1
Description
Properties
Density | 1.64 |
---|
Safety
Symbol(GHS) | C |
---|---|
Hazard Codes | R22;R34 |
SDS/MSDS | S26;S36/37/39;S45 |
SDS
Source | SDS/MSDS Samples |
---|---|
Alfa-Aesar | View & Download |
Sigma-Aldrich | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex.Jun Zhu et al.Behavioural brain research, 148(1-2), 107-117 (2003-12-20)
Plasma membrane monoamine transporters: structure, regulation and function.Gonzalo E Torres et al.Nature reviews. Neuroscience, 4(1), 13-25 (2003-01-04)
Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6.T Hiroi et al.Biochemical pharmacology, 53(12), 1937-1939 (1997-06-15)
Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.H C Akunne et al.The Journal of pharmacology and experimental therapeutics, 268(3), 1462-1475 (1994-03-01)
[3H]GBR-12935 binding to cytochrome P450 in the human brain.P Allard et al.Journal of neurochemistry, 62(1), 342-348 (1994-01-01)
Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.Rita Gálosi et al.Behavioural brain research, 344, 57-64 (2018-02-18)
GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.Na-Ra Lee et al.The Journal of pharmacology and experimental therapeutics, 371(2), 526-543 (2019-08-16)
[3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.I Gordon et al.Life sciences, 55(3), 189-199 (1994-01-01)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!